Table 1.
Characteristics of the study population.
| Characteristics | |
|---|---|
| Number of participants (n) | 37 |
| Participants with 3 days data, n (%) | 1 (2.7%) |
| Participants with >3–<7 days data, n (%) | 9 (24.3%) |
| Participants with ≥7 days data, n (%) | 27 (72.9%) |
| Age (years) | 62.8 ± 10.5 |
| Sex, male/female (n) | 14/23 |
| BMI (kg/m2) | 29.6 ± 6.8 |
| HbA1c (mmol/mol), (n = 15 missing) | 47.7 ± 10.6 |
| HbA1c (%), (n = 15 missing) | 6.6 ± 0.9 |
| Diabetes management (n) | |
| No medication/diet modification alone | 12 |
| Metformin | 18 |
| Metformin + sulfonylurea | 5 |
| Metformin + gliptin | 1 |
| Metformin + sulfonylurea + gliptin | 1 |
| Alcohol consumption (n) | |
| Non-consumer | 18 |
| Low consumer (≤14 units per week) | 18 |
| High consumer (>14 units per week) | 1 |
| Smoking status (n) | |
| Non-smoker | 34 |
| Smoker | 3 |
| Carbohydrate intake (g/day) | 125.3 ± 21.1 |
| Energy expenditure (MET × h/day) | 33.6 ± 1.3 |
| Sedentary time (h/day) | 9.8 ± 1.8 |
| Breaks in sedentary time (n/day) | 52 ± 13 |
| Standing time (h/day) | 4.0 ± 1.5 |
| Walking time (h/day) | 1.6 ± 0.6 |
| MVPA time (min/day) | 32.1 ± 22.7 |
| CGM and activPAL3 recording time (days) | 10 ± 3.4 |
| CGM recording h/day | 22.4 ± 1.8 |
| Time in hypoglycaemia (% of recording h/day) | 3.7 ± 6.9 |
| Time in euglycaemia (% of recording h/day) | 64.7 ± 25.5 |
| Time in hyperglycaemia (% of recording h/day) | 32.1 ± 27.4 |
| Time above target (% of recording h/day) | 19.2 ± 20.8 |
| Hypoglycaemic events (n/day) | 0.7 ± 1.0 |
| Euglycaemic events (n/day) | 3.9 ± 1.1 |
| Hyperglycaemic events (n/day) | 2.9 ± 1.3 |
| Events above target (n/day) | 2.3 ± 1.4 |
Data are means ± SD or number (n). BMI, body mass index; MET, metabolic equivalent task.